JAMP Pharma Group signs a landmark partnership agreement

JAMP Pharma Group signs a landmark partnership agreement

Canadian pharmaceutical company JAMP Pharma Group has signed an exclusive agreement with global speciality biopharmaceutical company Alvotech for the Canadian commercial rights to five biosimilars. The current market value of the branded sales for these five biosimilars is estimated to be exceeding $2 billion annually in Canada.  Read the Press Release

 

Member Forum

September 13, 2022
Angus Glen Golf Club
Markham, Ontario

MORE INFO

Boot Camp

November 22 - 23, 2022
Virtual Event

MORE INFO

Executive Conference

January 9 - 10, 2023
Montreal Airport Marriott In-Terminal Hotel

MORE INFO

Annual Conference

May 7 - 10, 2023
Sheraton Grand Nashville
Tennessee

MORE INFO